Latest news
Zymeworks Inc. Stock 12‑Month Price Target Raised to $40, Implies 73% Upside - TradingViewTradingView · Fri, 07 Aug 2026 06:20:00 GMTZymeworks Inc. Q2 2026: Revenue $4.6M, EPS $(0.62) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:36:00 GMTZYME: Net loss of $45M in Q2 2026; major milestones and acquisition expected to boost revenue - TradingViewTradingView · Thu, 06 Aug 2026 20:14:15 GMTZYME: Revenue fell 91% year-over-year, with a net loss of $89.2M and a major acquisition pending - TradingViewTradingView · Thu, 06 Aug 2026 20:14:00 GMTZYME Q2'26 Earnings: EPS estimate is (0.54) USD - TradingViewTradingView · Wed, 05 Aug 2026 11:01:09 GMTZymeworks Inc. Revenue Breakdown – NASDAQ:ZYME - TradingViewTradingView · Fri, 31 Jul 2026 23:36:09 GMT